2026 年 1 月 9 日 -11 日，「2026 乳腺癌北方沙龙·年度进展回顾」在北京隆重召开，汇聚国内乳腺癌领域的众多权威专家学者，共绘乳腺癌诊疗发展新蓝图。晚期三阴性乳腺癌（mTNBC）长期以来患者预后较差，临床治疗需求迫切。近年来，随着对 ...

Researchers developed a liquid biopsy method that improved detection of live circulating tumor cells in triple negative ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

引言2022 年全球乳腺癌的新发病例数接近 230 万例，死亡病例约为 67 万例，在女性肿瘤中的发病率和死亡率均排名第一[1]。根据 2022 年国家癌症中心的最新统计，中国乳腺癌新发病例数 35.72 万例，在女性癌症中仅次于肺癌，占比为 ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread.

Discover how Pitavastatin, a cholesterol-lowering drug, shows promise as a treatment for triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

Scientists have developed a blood test that can help predict which breast cancer treatment will work best. The team at the ...

Researchers at University of California San Diego have identified a previously unrecognized treatment target for ...

Beyond the Gates is doing important work in raising awareness about breast cancer through a storyline that will resonate with ...